All articles by Asha Sankanna
Asha Sankanna
New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World
Hub will focus on supporting global use of new treatments that effectively treated drug-resistant TB in 98% of Filipino participants
XRP Healthcare Partner with NHS collaborator Isansys Lifecare to Revolutionize Healthcare Services in Uganda
XRP Healthcare is thrilled to announce a strategic partnership with Isansys Lifecare, a leading innovator in the digital healthcare technology sector, to enhance healthcare infrastructure and services across Uganda. This collaboration is set to transform patient care through the integration of advanced patient monitoring systems into the pharmacies, medical centres and hospitals they are set to acquire during this year throughout the country.
TNO launches Peregrion to boost market impact of its technology that accelerates medicine development
TNO spin-off Peregrion brings science to the marketplace
New Real-World Data Further Support the Use of Veklury® (Remdesivir) for People Hospitalized With COVID-19
Gilead Sciences, Inc. (Nasdaq: GILD) today announced new data from three real-world retrospective studies being presented at the 31st Conference on Retroviruses and Opportunistic Infections (CROI).
Hybribio Calls for Raising International HPV Awareness
March 4th 2024 marks the 7th International HPV Awareness Day, a global campaign proposed by the International Papillomavirus Society (IPVS) since 2018. This year, the theme is One Less Worry. On this special day, Hybribio (300639.SZ) calls for raising international HPV awareness and adopting effective strategies for early detection and prevention.
SEKISUI Diagnostics Receives Emergency Use Authorization for the OSOM® Flu SARS-CoV-2 Combo Test
SEKISUI Diagnostics, a global medical diagnostics manufacturer, has received EUA clearance for the OSOM Flu SARS-CoV-2 Combo Test for use in professional and home testing settings.
Diasorin receives FDA 510(k) clearance for its Liaison Plex® System, the new multiplexing platform of the group, together with the Liaison Plex® Respiratory Panel
Diasorin (FTSE MIB: DIA) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the company’s new LIAISON PLEX® platform as well as its first panel of tests, the LIAISON PLEX® Respiratory Flex Assay.
Greenway and Luma team up on patient engagement solution
Greenway Patient Connect aims to support three daily elements of a patient’s experience – access, communication, and readiness.
GE HealthCare and Biofourmis partner to enhance post-hospital care
Biofourmis’ care-at-home solutions include wearable devices, digital platforms, and in-home services orchestration technology.
On-Device AI Healthcare Company Noul Becomes First Korean Diagnostic Company to Join Swiss Malaria Group
Noul Co., Ltd., (376930.KR), an On-Device AI healthcare company, announced that its European subsidiary (noul GmbH) has become an official member of the Swiss Malaria Group, a Swiss public, private, academic & civil society leadership network for a malaria-free world.